Voloridge Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $136M | Buy |
+147,903
| New | +$150M | 0.55% | 24 |
|
|
2025
Q1 | – | Sell |
-33,258
| Closed | -$25.7M | – | 1288 |
|
|
2024
Q4 | $25.7M | Sell |
33,258
-60,742
| -65% | -$50.3M | 0.09% | 282 |
|
|
2024
Q3 | $83.3M | Buy |
+94,000
| New | +$84.5M | 0.3% | 75 |
|
|
2023
Q4 | – | Sell |
-157,553
| Closed | -$84.6M | – | 1332 |
|
|
2023
Q3 | $84.6M | Buy |
157,553
+144,269
| +1,086% | +$74.3M | 0.42% | 50 |
|
|
2023
Q2 | $6.23M | Sell |
13,284
-105,755
| -89% | -$44.4M | 0.03% | 597 |
|
|
2023
Q1 | $40.9M | Buy |
119,039
+49,044
| +70% | +$16.5M | 0.2% | 146 |
|
|
2022
Q4 | $25.6M | Buy |
+69,995
| New | +$24.8M | 0.14% | 205 |
|
|
2021
Q4 | – | Sell |
-73,470
| Closed | -$17M | – | 1720 |
|
|
2021
Q3 | $17M | Buy |
+73,470
| New | +$18.1M | 0.11% | 252 |
|
|
2021
Q1 | – | Sell |
-45,460
| Closed | -$7.67M | – | 1545 |
|
|
2020
Q4 | $7.67M | Sell |
45,460
-290,507
| -86% | -$43.4M | 0.06% | 353 |
|
|
2020
Q3 | $49.7M | Sell |
335,967
-146,598
| -30% | -$22.7M | 0.41% | 47 |
|
|
2020
Q2 | $79.2M | Buy |
482,565
+441,846
| +1,085% | +$67.8M | 0.91% | 14 |
|
|
2020
Q1 | $5.65M | Sell |
40,719
-96,197
| -70% | -$13.2M | 0.16% | 138 |
|
|
2019
Q4 | $18M | Sell |
136,916
-34,020
| -20% | -$3.94M | 0.35% | 54 |
|
|
2019
Q3 | $19.1M | Buy |
170,936
+76,225
| +80% | +$8.49M | 0.33% | 46 |
|
|
2019
Q2 | $10.5M | Buy |
+94,711
| New | +$11.2M | 0.29% | 71 |
|
|
2019
Q1 | – | Sell |
-7,146
| Closed | -$827K | – | 1011 |
|
|
2018
Q4 | $827K | Buy |
+7,146
| New | +$798K | 0.04% | 291 |
|
|
2018
Q1 | – | Sell |
-173,732
| Closed | -$14.7M | – | 580 |
|
|
2017
Q4 | $14.7M | Buy |
173,732
+16,774
| +11% | +$1.43M | 0.32% | 70 |
|
|
2017
Q3 | $13.4M | Sell |
156,958
-75,509
| -32% | -$6.19M | 0.3% | 78 |
|
|
2017
Q2 | $19.1M | Buy |
+232,467
| New | +$19M | 0.48% | 53 |
|
|
2016
Q3 | – | Sell |
-79,812
| Closed | -$6.29M | – | 292 |
|
|
2016
Q2 | $6.29M | Sell |
79,812
-582,288
| -88% | -$43.8M | 0.18% | 123 |
|
|
2016
Q1 | $47.7M | Buy |
+662,100
| New | +$50.1M | 1.12% | 15 |
|
|
2015
Q3 | – | Sell |
-327,633
| Closed | -$27.4M | – | 350 |
|
|
2015
Q2 | $27.4M | Sell |
327,633
-61,532
| -16% | -$4.69M | 1.39% | 15 |
|
|
2015
Q1 | $28.3M | Buy |
389,165
+366,640
| +1,628% | +$26.1M | 1.37% | 15 |
|
|
2014
Q4 | $1.55M | Sell |
22,525
-44,727
| -67% | -$3.02M | 0.09% | 129 |
|
|
2014
Q3 | $4.36M | Sell |
67,252
-377,310
| -85% | -$23.9M | 0.2% | 53 |
|
|
2014
Q2 | $27.6M | Buy |
+444,562
| New | +$26.5M | 2.64% | 5 |
|
|
2014
Q1 | – | Sell |
-37,042
| Closed | -$1.89M | – | 109 |
|
|
2013
Q4 | $1.89M | Buy |
+37,042
| New | +$1.85M | 0.36% | 62 |
|
Other funds holding LLY
VCM
VPM
Voloridge Investment Management's LLY Position: Q1 2026 in Review
Voloridge Investment Management opened a new position in Eli Lilly (LLY) in Q1 2026: 147,903 shares worth $136M. The stake represents 0.55% of the portfolio and ranks #24 among its holdings. This is a return to the name: Voloridge Investment Management previously reported a position in LLY as recently as Q4 2024.
Voloridge Investment Management first reported a position in LLY in Q4 2013 and has held it in 27 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Voloridge Investment Management held 147,903 shares of Eli Lilly worth $136M as of Q1 2026.
- Eli Lilly was a new Voloridge Investment Management position in Q1 2026.
- Eli Lilly made up 0.55% of Voloridge Investment Management's portfolio in Q1 2026, its #24 holding.
- Voloridge Investment Management first reported a position in Eli Lilly in Q4 2013 and has held it in 27 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.